VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77 | +2.7% | 17,805 | +57.1% | 0.00% | – |
| Q2 2023 | $75 | -84.8% | 11,335 | -84.4% | 0.00% | -100.0% |
| Q1 2023 | $494 | +69.8% | 72,693 | +84.6% | 0.00% | – |
| Q4 2022 | $291 | -99.9% | 39,376 | -0.1% | 0.00% | -100.0% |
| Q3 2022 | $389,000 | -60.6% | 39,399 | -56.5% | 0.00% | 0.0% |
| Q2 2022 | $988,000 | +121.0% | 90,628 | +129.5% | 0.00% | – |
| Q1 2022 | $447,000 | -27.8% | 39,493 | +0.1% | 0.00% | -100.0% |
| Q4 2021 | $619,000 | -50.0% | 39,460 | -45.4% | 0.00% | 0.0% |
| Q3 2021 | $1,239,000 | +23.4% | 72,266 | +54.9% | 0.00% | 0.0% |
| Q2 2021 | $1,004,000 | +44.7% | 46,653 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $694,000 | +17.0% | 46,200 | +2.4% | 0.00% | 0.0% |
| Q4 2020 | $593,000 | +36.0% | 45,100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $436,000 | -15.5% | 45,100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $516,000 | +10.5% | 45,100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $467,000 | -36.9% | 45,100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $740,000 | +7.4% | 45,100 | -13.1% | 0.00% | 0.0% |
| Q3 2019 | $689,000 | -5.7% | 51,900 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $731,000 | -23.5% | 51,900 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $955,000 | -29.6% | 51,900 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $1,356,000 | +3.5% | 51,900 | -9.1% | 0.00% | 0.0% |
| Q3 2018 | $1,310,000 | +8.5% | 57,100 | -9.9% | 0.00% | 0.0% |
| Q2 2018 | $1,207,000 | +34.3% | 63,370 | +18.7% | 0.00% | +100.0% |
| Q1 2018 | $899,000 | +10.9% | 53,370 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $811,000 | -15.1% | 53,370 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $955,000 | +9.8% | 53,370 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $870,000 | +33.4% | 53,370 | +14.6% | 0.00% | 0.0% |
| Q1 2017 | $652,000 | -72.4% | 46,571 | -68.6% | 0.00% | -66.7% |
| Q4 2016 | $2,363,000 | -4.2% | 148,170 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $2,466,000 | +446.8% | 148,170 | +267.7% | 0.00% | +300.0% |
| Q2 2016 | $451,000 | +33.8% | 40,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $337,000 | -10.1% | 40,300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $375,000 | -17.6% | 40,300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $455,000 | -11.0% | 40,300 | +0.0% | 0.00% | 0.0% |
| Q2 2015 | $511,000 | – | 40,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |